The TGFR, which includes Lumitrace (relmapirazin), was approved on January 17th by the U.S. Food and Drug Administration (FDA). MediBeacon continues development of future TGFR products including a ...
Medmira ( ($TSE:MIR) ) has provided an update. MedMira Inc. has announced an exclusive distribution agreement with Trimedic Inc. to expand its ...
The White House on Tuesday named Amy Gleason as the acting administrator of the White House DOGE office following weeks of ...
Right now, there is only one heart pump on the market offered for short and long-term treatment of heart failure. A national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback